StockGuru Blog: Renhuang Pharmaceuticals (RHGP) – Pub Med Findings on Siberian Ginseng Impressive
Stock Guru Profile News Blogs Renhuang Pharmaceuticals, Inc. (RHGP) believes a company should generate revenue to support its research and development! Their earnings support this philosophy. The fiscal year-to-date results covering the nine months from October 1, 2006 to July 31, 2007, indicate net earnings of $8.46 million on solid sales of about $21 million, more than doubling the net earnings of $3.08 million for the Company’s operating subsidiary for the same period of the previous year. RHGP controls an estimated 70% of China’s natural resources of Acanthopanax (also known as Siberian Ginseng), the Company possesses a unique competitive edge…